Abstract:Abstract. The stability of oligodeoxynucleotides to trifluoroacetic acid is studied.Pyrimidine oligonucleotides were stable in the conditions used for the removal of tbutyl groups.Oligonucleotide-3'-peptide conjugates carrying pyrimidine oligonucleotides are prepared stepwise using peptide-supports and Fmoc, t-butyl strategy. Using this strategy we have prepared an oligonucleotide-peptide conjugate containing as peptide the leucine-rich fragment of FOS, a transcription factor involved in many important cellula… Show more
“…In this way, the standard Fmo/ t -Bu strategy was used to synthesize the peptide; however, this method requires the use of TFA in the presence of the oligonucleotide, which may induce depurination. Although some authors have described the isolation of OPCs after TFA treatment [ 34 ], we found that purine 2′-deoxynucleotides are not stable to TFA [ 35 ]. For this reason the method may be restricted to polypyrimidine sequences [ 35 , 36 ].…”
Section: Resultsmentioning
confidence: 88%
“…Both protocols gave the desired conjugate as a major product but the yield was higher in the first. Nevertheless, this method allows the synthesis of only pyrimidine sequences, as these are stable to TFA [ 35 , 36 ].…”
Here we used solid-phase methods to prepare oligonucleotides carrying fibrin/ filaggrin citrullinated peptides. Post-synthetic conjugation protocols were successfully applied for the synthesis of oligonucleotides carrying small peptides. A stepwise protocol using acid treatment for the final deprotection allowed the preparation of polypyrimidine oligonucleotides carrying longer and arginine-rich peptides. An ELISA-based test using the oligonucleotide-citrullinated peptide conjugates was developed for the detection of anti-citrullinated protein/peptide antibodies in human serum from rheumatoid arthritis patients.
“…In this way, the standard Fmo/ t -Bu strategy was used to synthesize the peptide; however, this method requires the use of TFA in the presence of the oligonucleotide, which may induce depurination. Although some authors have described the isolation of OPCs after TFA treatment [ 34 ], we found that purine 2′-deoxynucleotides are not stable to TFA [ 35 ]. For this reason the method may be restricted to polypyrimidine sequences [ 35 , 36 ].…”
Section: Resultsmentioning
confidence: 88%
“…Both protocols gave the desired conjugate as a major product but the yield was higher in the first. Nevertheless, this method allows the synthesis of only pyrimidine sequences, as these are stable to TFA [ 35 , 36 ].…”
Here we used solid-phase methods to prepare oligonucleotides carrying fibrin/ filaggrin citrullinated peptides. Post-synthetic conjugation protocols were successfully applied for the synthesis of oligonucleotides carrying small peptides. A stepwise protocol using acid treatment for the final deprotection allowed the preparation of polypyrimidine oligonucleotides carrying longer and arginine-rich peptides. An ELISA-based test using the oligonucleotide-citrullinated peptide conjugates was developed for the detection of anti-citrullinated protein/peptide antibodies in human serum from rheumatoid arthritis patients.
“…After acidolytic detritylation, an oligothymidylate sequence has been assembled by phosphoramidite chemistry. Consecutive treatments with piperidine in DMF and 95% TFA have then given the conjugate (153). The question that remains to be answered is whether a heterosequence withstands without depurination the acidolytic removal of the tBu-derived side-chain protecting groups.…”
Olignucleotide-based drugs show promise as a novel form of chemotherapy. Among the hurdles that have to be overcome on the way of applicable nucleic acid therapeutics, inefficient cellular uptake and subsequent release from endosomes to cytoplasm appear to be the most severe ones. Covalent conjugation of oligonucleotides to molecules that expectedly facilitate the internalization, targets the conjugate to a specific cell-type or improves the parmacokinetics offers a possible way to combat against these shortcomings. Since workable chemistry is a prerequisite for biological studies, development of efficient and reproducible methods for preparation of various types of oligonucleotide conjugates has become a subject of considerable importance. The present review summarizes the advances made in the solid-supported synthesis of oligonucleotide conjugates aimed at facilitating the delivery and targeting of nucleic acid drugs.
“…Another promising approach is total stepwise solid-phase synthesis, in which the desired POC is assembled directly on a solid support and therefore requires only one-step purification. [17][18][19][20][21][22] Nevertheless, this seemingly simple method can be applied to only a limited number of amino acids, because removal of the sidechain protecting groups of the amino acids requires trifluoroacetic acid (TFA) treatment, which can induce depurination of the oligonucleotide (Scheme 1a). 7 In order to solve this problem, the side-chain functional groups of amino acids were temporarily protected using base-labile protecting groups.…”
A practical strategy for total stepwise solid-phase synthesis of peptide-oligonucleotide conjugates was developed. In this strategy, Boc/tBu protection group is utilized for the side chains of Trp, His, Arg, Asp,...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.